Plaintiffs say the products, marketed mainly to Black women, contain chemicals such as phthalates. These substances disrupt the endocrine system, causing breast and uterine cancers, uterine fibroids, and other harm, plaintiffs say.
- Combining the suits into a single proceeding will make the litigation fairer and more efficient, the panel said
- A unified proceeding will prevent inconsistent rulings on early issues such as what level of exposure to phthalates or ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.